Skip to main content
SpringerLink
Log in

Antidepressants

From Biogenic Amines to New Mechanisms of Action

  • Book
  • © 2019

Overview

Editors:
  1. Matthew Macaluso

    1. School of Medicine-Wichita, University of Kansas, Wichita, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Sheldon H. Preskorn

    1. School of Medicine-Wichita, University of Kansas, Wichita, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Outlines the most up to date evidence regarding the treatment of depression
  • Concise, yet comprehensive, in its review of clinical evidence
  • Appeals to both clinicians and researchers alike

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 250)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. Impact, Diagnosis, Phenomenology, and Biology

    • William Coryell
    Pages 3-33

  3. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?

    • Ravikumar Chockalingam, Britt M. Gott, Charles R. Conway
    Pages 37-48

  4. Clinical Implications of the STAR*D Trial

    • A. John Rush, Shailesh (Bobby) Jain
    Pages 51-99

  5. Pharmacogenomics and Biomarkers of Depression

    • Manish K. Jha, Madhukar H. Trivedi
    Pages 101-113

  6. Therapeutic Drug Monitoring of Antidepressants

    • Najla Fiaturi, David J. Greenblatt
    Pages 115-133

  7. Selective Serotonin Reuptake Inhibitors

    • Dee Lochmann, Tara Richardson
    Pages 135-144

  8. Serotonin and Norepinephrine Reuptake Inhibitors

    • Richard C. Shelton
    Pages 145-180

  9. Neurostimulation Therapies

    • Nicholas T. Trapp, Willa Xiong, Charles R. Conway
    Pages 181-224

  10. Current Role of Herbal and Natural Preparations

    • David Mischoulon, Mark Hyman Rapaport
    Pages 225-252

  11. Role of Inflammation in Depression and Treatment Implications

    • Jennifer C. Felger
    Pages 255-286

  12. NMDA Antagonists for Treatment-Resistant Depression

    • Nuri B. Farber
    Pages 287-305

  13. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development

    • Sheldon H. Preskorn
    Pages 307-324

  14. Other Antidepressants

    • T. E. Schwasinger-Schmidt, M. Macaluso
    Pages 325-355

  15. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders

    • Theadia L. Carey
    Pages 359-370

  16. Treatment of Depression in Women

    • Christina Bourne, Laura Kenkel
    Pages 371-387

  17. Management of Late-Life Depression

    • J. Craig Nelson
    Pages 389-413

  18. The Use of Antidepressants in Bipolar Depression

    • John L. Beyer
    Pages 415-442
Back to top

Keywords

About this book

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.

Editors and Affiliations

  • School of Medicine-Wichita, University of Kansas, Wichita, USA

    Matthew Macaluso, Sheldon H. Preskorn

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation